<div class="dlp">
    <h1>
        TB-ARC Antibiotic Resistance Catalog
    </h1>
    <section class="main">
        <div class="data-box">
            <p>&nbsp;</p>
            <h3>
                <a href="http://www.broadinstitute.org/science/projects/gscid/genomic-sequencing-center-infectious-diseases"
                   target="_blank"><img src="/public/patric/images/Broad-logo-300x75.jpeg" alt="Broad logo" width="208"
                                        height="53"></a>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<b><a
                    href="https://olive.broadinstitute.org/projects/tb_arc"
                    target="_blank">TB Antibiotic Resistance Catalog at Broad</a></b><b></b></h3>
            <p>&nbsp;</p>
            <p>The overarching goal of the Broad TB-ARC project is to identify the entire complement of naturally
                occurring mutations that are responsible for drug resistance (DR) in clinical&nbsp;<em>Mycobacterium
                    tuberculosis</em>&nbsp;(Mtb).</p>
            <p>The plan is to create a comprehensive catalog of DR-conferring mutations by sequencing large numbers of
                geographically and phenotypically diverse <em>M. tuberculosis</em> complex strains that have been
                quantitatively characterized for their resistance to a broad spectrum of first and second line
                antibiotics.&nbsp;The DR catalog will provide a critical resource for addressing some of the most
                pressing needs in treating tuberculosis (TB) in the clinic:</p>
            <ol>
                <li>Rapid tests for accurate diagnosis of drug resistance in TB to guide treatment</li>
                <li>Identifying new targets for developing improved anti-TB therapeutics</li>
            </ol>
            <p>Among bacterial diseases, TB is the leading cause of death worldwide, with an estimated 1.3 million
                deaths attributed to TB in 2008. Though historically treatable with standard first-line anti-TB therapy
                (primarily rifampin, isoniazid, pyrazinamide and sometimes ethambutol), new strains are emerging that
                are resistant to some and, in some reports,&nbsp;all&nbsp;first and second line antibiotics
                (fluoroquinolones and aminoglycosides). The inability of clinicians to quickly and accurately determine
                the DR profile of strains associated with new clinical cases of TB further confounds TB treatment and
                control leading to long delays in treatment and, worse yet, treatment with unnecessary drugs that
                increase the opportunity for new DR forms of the bacterium to arise and spread.</p>
            <p>At present the knowledge of DR-mutations is woefully incomplete. The fact that we can only identify 85%
                of the causative mutations for isoniazid resistance, one of the best-studied drugs for mechanism of
                action in Mtb, underscores the need for a massive effort to comprehensively identify the mutations
                associated with DR in TB. These mutations, in turn, will become the basis for new tests for
                resistance.</p>
            <p>A further concern is that the DR strains are showing extremely high levels of virulence, both in their
                ability to rapidly spread from person &nbsp;to person as well as causing rapid disease progression.&nbsp;Thus,
                there is an urgent need to identify those compensatory mutations that allow DR organisms to thrive as
                rampantly disseminating, highly successful pathogens. These compensatory mutations will appear as part
                of the DR catalog by virtue of their association with resistance phenotypes.</p>
            <p>To create the needed catalog of DR mutations, Broad researchers are working in partnership with leading
                TB clinical researchers who hold collections of phenotypically characterized Mtb strains from patients
                across the globe. These geographically disparate collections of strains will allow identification of
                DR-causing mutations that are common and distinct among different Mtb genetic backgrounds
                (lineages).</p>
            <p>The data sets are</p>
            <ul>
                <li class="first"><a title="TB-ARC Belarus" href="/content/tb-arc-belarus">TB-ARC Belarus</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/Belarus.1.tar.gz" download="">143
                    strain variant files</a> — Comparative sequence analysis of <em>M. tuberculosis</em> isolates from
                    Patients with multi- and extensively drug resistant tuberculosis in Belarus
                </li>
                <li><a href="/content/tb-arc-cdrc">TB-ARC CDRC</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/CDRC.1.tar.gz">179 strain variant
                    files</a>&nbsp;— Whole genome sequencing of clinical strains of <em>M. tuberculosis</em></li>
                <li><a href="/content/tb-arc-india">TB-ARC India</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/India.1.tar.gz">223 strain
                    variant files</a>&nbsp;— Whole Genome Sequencing for understanding TB transmission and evolution of
                    drug resistant mutations in South India
                </li>
                <li><a href="/content/tb-arc-iran">TB-ARC Iran</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/Iran.1.tar.gz">32 strain variant
                    files</a>&nbsp;— Genomic changes at XDR and TDR <em>M. tuberculosis</em> bacilli
                </li>
                <li><a href="/content/tb-arc-k-rith-ii">TB-ARC K-RITH II</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/KRITH_II.tar.gz">182 strain
                    variant files</a>&nbsp;— Identifying Mechanisms of Drug Resistance in <em>M. tuberculosis</em></li>
                <li><a href="/content/tb-arc-k-rith-kwazulu-natal">TB-ARC K-RITH KwaZulu-Natal</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/KwaZulu-Natal.3.tar.gz">219&nbsp;strain
                    variant files</a>&nbsp;&nbsp;—&nbsp;&nbsp;Characterization of<em> M. tuberculosis</em> Resistance
                    Through Whole Genome Sequence Analysis to Support Diagnostic Development, Drug Discovery, and
                    Molecular Epidemiology
                </li>
                <li><a href="/content/tb-arc-m-bovis">TB-ARC M. bovis</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/bovis.1.tar.gz">8 strain variant
                    files</a>&nbsp;— Genome-scale Global Population Genetic Frameworks of <em>M. bovis</em></li>
                <li><a href="/content/tb-arc-mali">TB-ARC Mali</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/Mali.1.tar.gz">92 strain variant
                    files</a>&nbsp;— A Proposal to Compare the Genomes of MDR and Susceptible <em>M. africanum</em> and
                    <em>M. tuberculosis</em> from Mali
                </li>
                <li><a href="/content/tb-arc-moldova">TB-ARC Moldova</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/Moldova.1.tar.gz">95 strain
                    variant files</a>— Sequencing <em>M. tuberculosis</em> isolates from the Republic of Moldova to
                    characterize transmission dynamics and improve control of drug-resistant TB
                </li>
                <li><a href="/content/tb-arc-mrc-sa">TB-ARC MRC SA</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/SA.1.tar.gz">189 strain variant
                    files</a>&nbsp;— Preserving Effective TB Treatment Study (PETTS) Samples from the South African
                    Medical Research Council for sequencing
                </li>
                <li><a href="/content/tb-arc-ntu-taiwan">TB-ARC NTU Taiwan</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/Taiwan.2.tar.gz">40&nbsp;strain
                    variant files</a>&nbsp;—&nbsp;Understanding Resistance to &nbsp;Fluoroquinolones in the Treatment of
                    MDR TB in Taiwan
                </li>
                <li><a href="/content/tb-arc-romania">TB-ARC Romania</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/Romania.1.tar.gz">34 strain
                    variant files</a>— Romanian clinical isolates of multi-drug resistant Tuberculosis strains
                </li>
                <li class="last"><a href="/content/tb-arc-sweden">TB-ARC Sweden</a>&nbsp;— <a
                        href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped/Sweden.1.tar.gz">150 strain
                    variant files</a>&nbsp;— Whole Genome Sequencing of Swedish MDR-TB strains
                </li>
            </ul>
            <p>Data downloads for all variant files:</p>
            <ul>
                <li class="first"><a href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/broad_original.tar.gz">Broad
                    original variant files</a></li>
                <li class="last"><a href="ftp://ftp.patricbrc.org/BRC_Mirrors/TB-ARC/patric_mapped.tar.gz">PATRIC mapped
                    variant files</a></li>
            </ul>
            <p>See instructions on each project page to view individual SNP files on the PATRIC genome browser.</p>
            <p><img class="alignnone size-medium wp-image-4136"
                    src="/public/patric/images/snps_jbrowse_2.png"
                    alt="snps_jbrowse_2" width="300"
                    height="187"></p>

        </div>
    </section>
</div>
